Great exchange of blood! Since June, a number of senior managers of listed pharmaceutical companies have left their jobs

[industry trends of pharmaceutical Station] on July 12, Cr Shuanghe announced that the board of directors had received the resignation report submitted by Mr Li Guohui, who applied to resign from the 8th board of directors and the audit and Risk Management Committee of the board of directors due to the change of work After resigning, Mr Li Guohui will no longer hold any post in the company It is understood that this is not the first high-level personnel change of Cr pharma and its subsidiary CR Shuanghe since this year On March 21, 2019, Cr Pharma announced that the board of directors announced that Mr Fu Yuning resigned as chairman of the board of directors, non-executive director of the company and chairman of the nomination committee, effective from March 21, 2019 It is also announced that Mr Wang Chuncheng, executive director and executive officer of the company, has been appointed chairman of the board of directors and chairman of the nomination committee of the company, effective March 21, 2019 In fact, in recent years, the resignation of executives of listed pharmaceutical companies in the pharmaceutical industry has been frequent As far as I'm concerned, since June, there have been many senior managers of pharmaceutical companies in China who have chosen to resign The reasons for resignation mainly include personal reasons, job changes, leaving the post after reaching the retirement age, etc On June 29, Changsheng biology announced that Mr Wang Qun, director of R & D, resigned as director of R & D due to personal reasons Mr Wang Qun will no longer hold any post in the company after he resigns On the same day, Dongcheng pharmaceutical announced that Mr Yang Zhenqiu, deputy general manager, applied to resign from the post of deputy general manager of the company due to personal reasons, and will not hold any post in the company after resignation On June 26, Hansen pharmaceutical announced that Ms Yang Xiang, the representative of securities affairs, resigned as the representative of securities affairs of the company due to personal reasons, and she will no longer hold any post in the company after resigning On June 22, wohua pharmaceutical announced that Mr Du Peitian, the representative of securities affairs, requested to resign as a representative of securities affairs for personal reasons After resigning the post, Mr Du Peitian will not hold any other post in the company On June 19, Longjin pharmaceutical announced that Ms Rao Huaying, financial director and deputy general manager, resigned from the position of financial director and deputy general manager to the board of directors of the company due to personal reasons After resignation, she will not hold any post in the company and will not hold any post in the company after resignation On June 18, Taiji Group announced that Mr Bai Lixi, director and chairman of the board of directors, applied to resign as a director, chairman of the board of directors and chairman and member of the strategic committee of the board of directors due to job changes, and he no longer served as the legal representative of the company After resigning, Mr Bai Lixi will no longer hold other positions in the company On June 15, Lu Kang pharmaceutical announced that Mr Dong Chede, the supervisor, applied to resign as a supervisor of the company due to the change of work On June 12, Lianhuan pharmaceutical announced that Mr Zhang Lei, an independent director, applied for resignation from the position of independent director of the seventh board of directors, member of the nomination committee of the board of directors, member of the audit committee of the board of directors, convener and member of the remuneration and assessment committee of the board of directors due to personal reasons After resigning, Mr Zhang Lei will no longer hold any post in the company On the same day, Nanjing Pharmaceutical announced that Ms yuan Yujuan, chairman of the board of supervisors, applied to resign from the position of chairman and supervisor of the eighth board of supervisors of the company due to the change of work Ms yuan Yujuan will not hold any post in the company after resigning On June 10, Puli pharmaceutical announced that Mr Shen Shihua, deputy general manager, applied to resign from the post of deputy general manager of the company due to personal reasons After his resignation, Shen Shihua continued to hold other positions in the company On June 6, Zhejiang Pharmaceutical announced that Ms Wu Mengmeng, the securities affairs representative, had applied for resigning from the post of securities affairs representative for personal reasons and would no longer hold any post in the company after resigning On the same day, Jingfeng pharmaceutical announced that Mr Jian Weiguang, director and executive vice president of the company, had applied for resigning from the post of director and executive vice president of the company and various posts held by subsidiaries of the company due to personal reasons After resigning, Mr Jian Weiguang no longer holds any post in the company and its subsidiaries On June 3, Jinling pharmaceutical announced that Chen Sheng, the supervisor, resigned from the position of non employee supervisor due to work needs After Chen Sheng resigned, he continued to serve as a member of the company's Party committee and Secretary of the Discipline Inspection Commission On June 1, Sailong pharmaceutical announced that Mr Huang Jixiang, chief financial officer, applied to resign as chief financial officer of the company for personal reasons After resigning, Mr Huang Jixiang will no longer hold other positions in the company